Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma

Oncotarget
I-Ling HsuTse-Ming Hong

Abstract

Ovarian clear cell carcinoma (OCCC) is an aggressive neoplasm with a high recurrence rate that frequently develops resistance to platinum-based chemotherapy. There are few prognostic biomarkers or targeted therapies exist for patients with OCCC. Here, we identified that FXYD2, the modulating subunit of Na+/K+-ATPases, was highly and specifically expressed in clinical OCCC tissues. The expression levels of FXYD2 were significantly higher in advanced-stage of OCCC and positively correlated with patients' prognoses. Silencing of FXYD2 expression in OCCC cells inhibited Na+/K+-ATPase enzyme activity and suppressed tumor growth via induction of autophagy-mediated cell death. We found that high FXYD2 expression in OCCC was transcriptionally regulated by the transcriptional factor HNF1B. Furthermore, up-regulation of FXYD2 expression significantly increased the sensitivity of OCCC cells to cardiac glycosides, the Na+/K+-ATPase inhibitors. Two cardiac glycosides, digoxin and digitoxin, had a great therapeutic efficacy in OCCC cells in vitro and in vivo. Taken together, our results demonstrate that FXYD2 is functionally upregulated in OCCC and may serve as a promising prognostic biomarker and therapeutic target of cardiac glycosides in ...Continue Reading

References

Jan 1, 1986·Kidney International·P L Jørgensen
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·N T MinorR W Mercer
Jun 5, 2002·Annual Review of Biochemistry·Jack H Kaplan
Feb 18, 2003·JAMA : the Journal of the American Medical Association·Saif S RathoreHarlan M Krumholz
Feb 18, 2005·Journal of Cellular Physiology·Francisco ArrebolaEduardo Fernández-Segura
Jun 24, 2005·Science's STKE : Signal Transduction Knowledge Environment·Jack H Kaplan
Nov 1, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Noriko KatoTeiichi Motoyama
Nov 18, 2006·The Oncologist·Dimitrios PectasidesTheofanis Economopoulos
Feb 28, 2008·Neurosurgery·Florence LefrancRobert Kiss
Mar 12, 2008·Molecular Interventions·Robert A NewmanKeith I Block
Feb 27, 2009·Journal of Cellular and Molecular Medicine·Véronique MathieuRobert Kiss
Mar 14, 2009·Current Opinion in Lipidology·Angela D Armendariz, Ronald M Krauss
Mar 31, 2009·The Journal of Biological Chemistry·Jiang TianZijian Xie
Apr 8, 2010·Oncology Reports·Hirotaka KajiharaHiroshi Kobayashi
Dec 7, 2010·Biochemical and Biophysical Research Communications·Silvia FerrèRené J M Bindels
Feb 1, 2011·Pharmacology & Therapeutics·Christos VaklavasApostolia Maria Tsimberidou
Feb 24, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael S AnglesioDavid D Bowtell
Apr 25, 2012·Gynecologic Oncology·Marcela G del CarmenJohn O Schorge
Jul 4, 2012·The International Journal of Biochemistry & Cell Biology·Yan WangZhen Wang
Jul 21, 2012·Science Translational Medicine·Laurie MengerGuido Kroemer
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
May 6, 2014·Stem Cell Research·Moustafa SayedJiang Tian

❮ Previous
Next ❯

Citations

Oct 1, 2019·PLoS Computational Biology·Olivier CollierJean-Philippe Vert
Mar 17, 2018·Frontiers in Pharmacology·Naira F Z SchneiderMarc Diederich
Feb 25, 2020·Cardiology Research and Practice·Alejandro Ogazon Del ToroArturo Ponce
Jan 19, 2021·Molecular and Cellular Biochemistry·Naira Fernanda Zanchett SchneiderCláudia Maria Oliveira Simões
Dec 23, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaoqiang SiShuyi Chenge
Aug 14, 2021·Oncology Letters·Sophia C ThemistocleousIoannis Patrikios

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE44104
GSE29450
GSE6008

Methods Mentioned

BETA
xenograft
immunoprecipitation
PCR

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms